Bristol-Myers Squibb Company (BMY)
NYSE: BMY · Real-Time Price · USD
65.31
+0.45 (0.69%)
At close: Jul 31, 2026, 4:00 PM EDT
65.40
+0.09 (0.13%)
After-hours: Jul 31, 2026, 7:58 PM EDT

BMY Revenue

Bristol-Myers Squibb Company had revenue of $12.97B in the quarter ending June 30, 2026, with 5.74% growth. This brings the company's revenue in the last twelve months to $49.19B, up 3.11% year-over-year. In the year 2025, Bristol-Myers Squibb Company had annual revenue of $48.19B, down -0.22%.

Revenue (ttm)
$49.19B
Revenue Growth
+3.11%
P/S Ratio
2.71
Revenue / Employee
$1,513,415
Employees
32,500
Market Cap
133.41B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202548.19B-106.00M-0.22%
Dec 31, 202448.30B3.29B7.32%
Dec 31, 202345.01B-1.15B-2.50%
Dec 31, 202246.16B-226.00M-0.49%
Dec 31, 202146.39B3.87B9.09%
Dec 31, 202042.52B16.37B62.62%
Dec 31, 201926.15B3.58B15.89%
Dec 31, 201822.56B1.79B8.59%
Dec 31, 201720.78B1.35B6.94%
Dec 31, 201619.43B2.87B17.31%
Dec 31, 201516.56B681.00M4.29%
Dec 31, 201415.88B-506.00M-3.09%
Dec 31, 201316.39B-1.24B-7.01%
Dec 31, 201217.62B-3.62B-17.05%
Dec 31, 201121.24B1.76B9.03%
Dec 31, 201019.48B676.00M3.59%
Dec 31, 200918.81B1.09B6.17%
Dec 31, 200817.72B2.10B13.43%
Dec 31, 200715.62B-591.00M-3.65%
Dec 31, 200616.21B-2.40B-12.88%
Dec 31, 200518.61B--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Merck & Co.65.77B
AbbVie64.39B
Pfizer63.32B
AstraZeneca61.37B
Novartis AG56.69B
Sanofi54.60B
Novo Nordisk50.57B
GSK plc44.05B
Revenue Rankings